Position in NVS
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$3,993,695
+$67,562 QoQ
Shares Held
25,483
-0.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
#305
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Telos Capital Management, Inc. holds $41,593,885 across 9 Drug Manufacturers - General names. NVS ranks #5 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
46,049 | $11,695,064 | |
| 2 | AMGN |
Amgen Inc
|
25,990 | $9,411,498 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
111,780 | $6,440,763 | |
| 4 | ABBV |
AbbVie Inc.
|
18,380 | $4,625,143 | |
| 5 | NVS |
Novartis AG
This page
|
25,483 | $3,993,695 | |
| 6 | LLY |
ELI LILLY & Co
|
2,302 | $2,761,088 | |
| 7 | MRK |
Merck & Co., Inc.
|
14,035 | $1,803,497 | |
| 8 | PFE |
Pfizer Inc
|
25,954 | $624,972 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,993,695 | 25,483 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $3,926,133 | 25,703 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $3,625,015 | 26,293 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $3,420,417 | 26,672 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $3,229,756 | 26,690 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $3,058,788 | 27,438 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $2,694,124 | 27,686 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $3,064,937 | 26,647 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $2,882,617 | 27,077 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,556,090 | 26,425 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $2,724,069 | 26,979 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $2,660,481 | 26,119 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $2,681,582 | 26,574 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $2,514,912 | 27,336 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $2,462,957 | 27,149 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $1,857,380 | 24,436 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $1,961,603 | 23,206 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,974,024 | 22,496 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $1,986,968 | 22,716 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $1,841,930 | 22,523 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $2,126,621 | 23,308 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $4,225,789 | 49,436 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $4,627,447 | 49,004 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $4,144,861 | 47,664 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $4,083,145 | 46,750 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $3,701,427 | 44,893 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||